Highlights Newsletter 3
This newsletter presents you the following key sessions:
2. Adavosertib effective in patients with RAS/TP53-mutant metastatic colorectal cancer
3. Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma
4. Sunitinib effective in malignant pheochromocytoma and paraganglioma
5. Vaccination against COVID-19 is safe and effective in patients with solid tumors